![]() |


![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (S)-nicotine | increases splicing | EXP | | 6480464 | Nicotine results in increased splicing of CDS1 mRNA alternative form | CTD | PMID:23825647 | 1,1-dichloroethene | decreases expression | ISO | RGD:737009 | 6480464 | vinylidene chloride results in decreased expression of CDS1 mRNA | CTD | PMID:26682919 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:737009 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDS1 mRNA | CTD | PMID:17942748 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CDS1 mRNA | CTD | PMID:19167446 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737009 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDS1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:737009 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDS1 mRNA | CTD | PMID:28213091 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:621185 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDS1 mRNA | CTD | PMID:21215274 | 2,4-dinitrotoluene | affects expression | ISO | RGD:621185 | 6480464 | 2, 4-dinitrotoluene affects the expression of CDS1 mRNA | CTD | PMID:21346803 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:737009 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of CDS1 mRNA | CTD | PMID:18648102 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:737009 | 6480464 | Fenretinide results in increased expression of CDS1 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:621185 | 6480464 | Propylthiouracil results in decreased expression of CDS1 mRNA | CTD | PMID:24780913 | acetylsalicylic acid | increases expression | ISO | RGD:621185 | 6480464 | Aspirin results in increased expression of CDS1 mRNA | CTD | PMID:12800193 | acrylamide | decreases expression | ISO | RGD:621185 | 6480464 | Acrylamide results in decreased expression of CDS1 mRNA | CTD | PMID:28959563 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDS1 mRNA | CTD | PMID:21934132 | ammonium chloride | affects expression | ISO | RGD:621185 | 6480464 | Ammonium Chloride affects the expression of CDS1 mRNA | CTD | PMID:16483693 | Aroclor 1254 | decreases expression | ISO | RGD:737009 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CDS1 mRNA | CTD | PMID:23650126 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of CDS1 mRNA | CTD | PMID:29633893 | benzo[a]pyrene | decreases expression | ISO | RGD:737009 | 6480464 | Benzo(a)pyrene results in decreased expression of CDS1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | multiple interactions | ISO | RGD:737009 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CDS1 mRNA] | CTD | PMID:22228805 | bisphenol A | increases expression | ISO | RGD:737009 | 6480464 | bisphenol A results in increased expression of CDS1 mRNA | CTD | PMID:26063408 | bisphenol F | increases expression | ISO | RGD:737009 | 6480464 | bisphenol F results in increased expression of CDS1 mRNA | CTD | PMID:30951980 | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of CDS1 mRNA | CTD | PMID:26079696 | butyric acid | increases expression | ISO | RGD:621185 | 6480464 | Butyric Acid results in increased expression of CDS1 mRNA | CTD | PMID:12800193 | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of CDS1 mRNA | CTD | PMID:16002434, PMID:26485663 | cobalt dichloride | decreases expression | ISO | RGD:621185 | 6480464 | cobaltous chloride results in decreased expression of CDS1 mRNA | CTD | PMID:24386269 | copper atom | decreases expression | ISO | RGD:621185 | 6480464 | Copper deficiency results in decreased expression of CDS1 mRNA | CTD | PMID:19821111 | copper(0) | decreases expression | ISO | RGD:621185 | 6480464 | Copper deficiency results in decreased expression of CDS1 mRNA | CTD | PMID:19821111 | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of CDS1 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CDS1 mRNA | CTD | PMID:27989131 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of CDS1 mRNA | CTD | PMID:29633893 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of CDS1 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of CDS1 mRNA | CTD | PMID:25529476 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CDS1 mRNA | CTD | PMID:29803840 | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of CDS1 mRNA | CTD | PMID:19244175 | endosulfan | increases expression | ISO | RGD:621185 | 6480464 | Endosulfan results in increased expression of CDS1 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA | CTD | PMID:19167446 | furan | increases expression | ISO | RGD:621185 | 6480464 | furan results in increased expression of CDS1 mRNA | CTD | PMID:25539665 | hypochlorous acid | decreases expression | ISO | RGD:737009 | 6480464 | Hypochlorous Acid results in decreased expression of CDS1 mRNA | CTD | PMID:19376150 | indole-3-methanol | affects expression | ISO | RGD:621185 | 6480464 | indole-3-carbinol affects the expression of CDS1 mRNA | CTD | PMID:21396975 | iron atom | decreases expression | ISO | RGD:621185 | 6480464 | Iron deficiency results in decreased expression of CDS1 mRNA | CTD | PMID:19821111 | iron(0) | decreases expression | ISO | RGD:621185 | 6480464 | Iron deficiency results in decreased expression of CDS1 mRNA | CTD | PMID:19821111 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of CDS1 mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | EXP | | 6480464 | Lead affects the expression of CDS1 mRNA | CTD | PMID:28903495 | mercury dibromide | increases expression | EXP | | 6480464 | mercuric bromide results in increased expression of CDS1 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA | CTD | PMID:27188386 | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of CDS1 mRNA | CTD | PMID:24449571 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CDS1 mRNA | CTD | PMID:24810058 | nicotine | increases splicing | EXP | | 6480464 | Nicotine results in increased splicing of CDS1 mRNA alternative form | CTD | PMID:23825647 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of CDS1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA | CTD | PMID:27188386 | pirinixic acid | decreases expression | ISO | RGD:737009 | 6480464 | pirinixic acid results in decreased expression of CDS1 mRNA | CTD | PMID:20813756 | pravastatin | increases expression | ISO | RGD:621185 | 6480464 | Pravastatin results in increased expression of CDS1 mRNA | CTD | PMID:27225895 | pravastatin | increases expression | ISO | RGD:737009 | 6480464 | Pravastatin results in increased expression of CDS1 mRNA | CTD | PMID:27225895 | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of CDS1 mRNA | CTD | PMID:26079696 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CDS1 mRNA | CTD | PMID:21632981 | rotenone | increases expression | ISO | RGD:621185 | 6480464 | Rotenone results in increased expression of CDS1 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of CDS1 mRNA | CTD | PMID:19244175 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of CDS1 mRNA | CTD | PMID:25895662 | tetrachloromethane | increases expression | ISO | RGD:621185 | 6480464 | Carbon Tetrachloride results in increased expression of CDS1 mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | RGD:621185 | 6480464 | Thioacetamide results in increased expression of CDS1 mRNA | CTD | PMID:23411599 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of CDS1 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA | CTD | PMID:27188386 | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of CDS1 mRNA | CTD | PMID:30510588 | valproic acid | increases expression | ISO | RGD:737009 | 6480464 | Valproic Acid results in increased expression of CDS1 mRNA | CTD | PMID:21427059 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CDS1 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA | CTD | PMID:27188386 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CDS1 mRNA | CTD | PMID:25979313 | vinclozolin | decreases expression | ISO | RGD:621185 | 6480464 | vinclozolin results in decreased expression of CDS1 mRNA | CTD | PMID:23555832 | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of CDS1 mRNA | CTD | PMID:19244175 | zaragozic acid A | increases expression | ISO | RGD:621185 | 6480464 | squalestatin 1 results in increased expression of CDS1 mRNA | CTD | PMID:27225895 | zaragozic acid A | increases expression | ISO | RGD:737009 | 6480464 | squalestatin 1 results in increased expression of CDS1 mRNA | CTD | PMID:27225895 | |
|
|
|
|
|
|
|
|
|
|
|
1. | Dong X, etal., Am J Hum Genet 2003 Feb;72(2):270-80. Epub 2003 Jan 17. |
2. | GOA_HUMAN data from the GO Consortium |
3. | Miller CW, etal., Genes Chromosomes Cancer 2002 Jan;33(1):17-21. |
4. | OMIM Disease Annotation Pipeline |
5. | Pipeline to import KEGG annotations from KEGG into RGD |
6. | Pipeline to import SMPDB annotations from SMPDB into RGD |
7. | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
8. | RGD automated import pipeline for gene-chemical interactions |
9. | Schutte M, etal., Am J Hum Genet 2003 Apr;72(4):1023-8. Epub 2003 Feb 27. |
PubMed | 8863531 8889548 9115637 9407135 9806839 9889000 10681541 12477932 15489334 16344560 16461635 19913121 20628086 21873635 25375833 26186194 26946540 28514442 28611215 |
CDS1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cds1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cds1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cds1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CDS1 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CDS1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cds1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CDS1 (Sus scrofa - pig) |
|
WI-11924 |
|
|||||||||||||||||||||||||||||||||||
SHGC-59679 |
|
|||||||||||||||||||||||||||||||||||
SHGC-59792 |
|
|||||||||||||||||||||||||||||||||||
SHGC-50798 |
|
|||||||||||||||||||||||||||||||||||
G16738 |
|
|||||||||||||||||||||||||||||||||||
SHGC-67258 |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NM_001263 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
XM_005262687 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017007648 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017007649 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017007650 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017007651 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AC104082 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AI673547 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK026697 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK314245 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AU139278 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC074833 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC074881 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BE504303 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CA313675 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471057 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DN915398 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
U60808 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
U65887 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001263 ⟹ NP_001254 | ||||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||||
Sequence: |
ACCTGGTGCGGGAGGCCCGGGCAGGGAGAAGTGTGCGGGGCCGGGACAAGCCGGCTCCGAGTCChide sequence |
RefSeq Acc Id: | XM_005262687 ⟹ XP_005262744 | ||||||||||||||
RefSeq Status: | |||||||||||||||
Type: | CODING | ||||||||||||||
Position: |
|
||||||||||||||
Sequence: |
GAAGTGTGCGGGGCCGGGACAAGCCGGCTCCGAGTCCGGCTCCGGGGGGCGGGGCGGGAGGGGChide sequence |
RefSeq Acc Id: | XM_017007648 ⟹ XP_016863137 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GAAGTGTGCGGGGCCGGGACAAGCCGGCTCCGAGTCCGGCTCCGGGGGGCGGGGCGGGAGGGGChide sequence |
RefSeq Acc Id: | XM_017007649 ⟹ XP_016863138 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GAAGTGTGCGGGGCCGGGACAAGCCGGCTCCGAGTCCGGCTCCGGGGGGCGGGGCGGGAGGGGChide sequence |
RefSeq Acc Id: | XM_017007650 ⟹ XP_016863139 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GAAGTGTGCGGGGCCGGGACAAGCCGGCTCCGAGTCCGGCTCCGGGGGGCGGGGCGGGAGGGGChide sequence |
RefSeq Acc Id: | XM_017007651 ⟹ XP_016863140 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GAAGTGTGCGGGGCCGGGACAAGCCGGCTCCGAGTCCGGCTCCGGGGGGCGGGGCGGGAGGGGChide sequence |
Protein RefSeqs | NP_001254 | (Get FASTA) | NCBI Sequence Viewer |
XP_005262744 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016863137 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016863138 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016863139 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016863140 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAC50735 | (Get FASTA) | NCBI Sequence Viewer |
AAC51184 | (Get FASTA) | NCBI Sequence Viewer | |
AAH74833 | (Get FASTA) | NCBI Sequence Viewer | |
AAH74881 | (Get FASTA) | NCBI Sequence Viewer | |
BAG36912 | (Get FASTA) | NCBI Sequence Viewer | |
EAX05950 | (Get FASTA) | NCBI Sequence Viewer | |
EAX05951 | (Get FASTA) | NCBI Sequence Viewer | |
Q92903 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_001254 ⟸ NM_001263 |
- UniProtKB: | Q92903 (UniProtKB/Swiss-Prot), A0A024RDG8 (UniProtKB/TrEMBL) |
- Sequence: |
MLELRHRGSCPGPREAVSPPHREGEAAGGDHETESTSDKETDIDDRYGDLDSRTDSDIPEIPPShide sequence |
RefSeq Acc Id: | XP_005262744 ⟸ XM_005262687 |
- Peptide Label: | isoform X2 |
- Sequence: |
MLELRHRGSCPGPREAVSPPHREGEAAGGDHETESTSDKETDIDDRYGDLDSRTDSDIPEIPPShide sequence |
RefSeq Acc Id: | XP_016863139 ⟸ XM_017007650 |
- Peptide Label: | isoform X4 |
- Sequence: |
MLELRHRGSCPGPREAVSPPHREGEAAGGDHETESTSDKETDIDDRYGDLDSRTDSDIPEIPPShide sequence |
RefSeq Acc Id: | XP_016863137 ⟸ XM_017007648 |
- Peptide Label: | isoform X1 |
- Sequence: |
MLELRHRGSCPGPREAVSPPHREGEAAGGDHETESTSDKETDIDDRYGDLDSRTDSDIPEIPPShide sequence |
RefSeq Acc Id: | XP_016863138 ⟸ XM_017007649 |
- Peptide Label: | isoform X3 |
- Sequence: |
MLELRHRGSCPGPREAVSPPHREGEAAGGDHETESTSDKETDIDDRYGDLDSRTDSDIPEIPPShide sequence |
RefSeq Acc Id: | XP_016863140 ⟸ XM_017007651 |
- Peptide Label: | isoform X5 |
- Sequence: |
MLELRHRGSCPGPREAVSPPHREGEAAGGDHETESTSDKETDIDDRYGDLDSRTDSDIPEIPPShide sequence |
RGD ID: | 6867906 | |||||||||
Promoter ID: | EPDNEW_H7118 | |||||||||
Type: | initiation region | |||||||||
Name: | CDS1_1 | |||||||||
Description: | CDP-diacylglycerol synthase 1 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 6867908 | |||||||||
Promoter ID: | EPDNEW_H7119 | |||||||||
Type: | initiation region | |||||||||
Name: | CDS1_2 | |||||||||
Description: | CDP-diacylglycerol synthase 1 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 6802121 | |||||||||
Promoter ID: | HG_KWN:48642 | |||||||||
Type: | CpG-Island | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, HeLa_S3, K562 | |||||||||
Transcripts: | NM_001263, UC003HPB.1 | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 4q12-22.3(chr4:51831622-97505618)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051772]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051772]|See cases [RCV000051772] | Chr4:51831622..97505618 [GRCh38] Chr4:52697788..98426769 [GRCh37] Chr4:52392545..98645792 [NCBI36] Chr4:4q12-22.3 |
pathogenic |
GRCh38/hg38 4q13.3-22.1(chr4:74031395-90421127)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053296]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053296]|See cases [RCV000053296] | Chr4:74031395..90421127 [GRCh38] Chr4:74897112..91342278 [GRCh37] Chr4:75115976..91561301 [NCBI36] Chr4:4q13.3-22.1 |
pathogenic |
GRCh38/hg38 4q21.21-22.1(chr4:79575748-92412449)x1 | copy number loss | Encephalopathy [RCV000053297]|See cases [RCV000053297] | Chr4:79575748..92412449 [GRCh38] Chr4:80496902..93333600 [GRCh37] Chr4:80715926..93552623 [NCBI36] Chr4:4q21.21-22.1 |
pathogenic |
GRCh38/hg38 4q21.22-21.3(chr4:82248692-86778340)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053319]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053319]|See cases [RCV000053319] | Chr4:82248692..86778340 [GRCh38] Chr4:83169845..87699493 [GRCh37] Chr4:83388869..87918517 [NCBI36] Chr4:4q21.22-21.3 |
pathogenic |
GRCh38/hg38 4q13.2-21.23(chr4:67869564-85517308)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053294]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053294]|See cases [RCV000053294] | Chr4:67869564..85517308 [GRCh38] Chr4:68735282..86438461 [GRCh37] Chr4:68417877..86657485 [NCBI36] Chr4:4q13.2-21.23 |
pathogenic |
NM_001263.3(CDS1):c.342+1467A>G | single nucleotide variant | Lung cancer [RCV000095053] | Chr4:84610992 [GRCh38] Chr4:85532145 [GRCh37] Chr4:4q21.23 |
uncertain significance |
GRCh38/hg38 4q21.21-22.3(chr4:80879777-94809447)x1 | copy number loss | See cases [RCV000134977] | Chr4:80879777..94809447 [GRCh38] Chr4:81800931..95730598 [GRCh37] Chr4:82019955..95949621 [NCBI36] Chr4:4q21.21-22.3 |
pathogenic |
GRCh38/hg38 4q21.23-21.3(chr4:84577519-86077547)x3 | copy number gain | See cases [RCV000135441] | Chr4:84577519..86077547 [GRCh38] Chr4:85498672..86998700 [GRCh37] Chr4:85717696..87217724 [NCBI36] Chr4:4q21.23-21.3 |
pathogenic |
GRCh38/hg38 4q21.21-21.23(chr4:79786514-85832807)x1 | copy number loss | See cases [RCV000136865] | Chr4:79786514..85832807 [GRCh38] Chr4:80707668..86753960 [GRCh37] Chr4:80926692..86972984 [NCBI36] Chr4:4q21.21-21.23 |
pathogenic |
GRCh38/hg38 4q21.23-22.1(chr4:84329551-87679204)x1 | copy number loss | See cases [RCV000136623] | Chr4:84329551..87679204 [GRCh38] Chr4:85250704..88600356 [GRCh37] Chr4:85469728..88819380 [NCBI36] Chr4:4q21.23-22.1 |
pathogenic |
GRCh38/hg38 4q21.21-24(chr4:80427023-100855441)x1 | copy number loss | See cases [RCV000137269] | Chr4:80427023..100855441 [GRCh38] Chr4:81348177..101776598 [GRCh37] Chr4:81567201..101995621 [NCBI36] Chr4:4q21.21-24 |
pathogenic |
GRCh38/hg38 4q13.3-21.3(chr4:72262258-86002147)x3 | copy number gain | See cases [RCV000138312] | Chr4:72262258..86002147 [GRCh38] Chr4:73127975..86923300 [GRCh37] Chr4:73346839..87142324 [NCBI36] Chr4:4q13.3-21.3 |
pathogenic |
GRCh38/hg38 4q21.23-22.2(chr4:84329551-93654474)x1 | copy number loss | See cases [RCV000139231] | Chr4:84329551..93654474 [GRCh38] Chr4:85250704..94575625 [GRCh37] Chr4:85469728..94794648 [NCBI36] Chr4:4q21.23-22.2 |
likely benign |
GRCh38/hg38 4q21.21-21.3(chr4:80043949-86948317)x1 | copy number loss | See cases [RCV000140416] | Chr4:80043949..86948317 [GRCh38] Chr4:80965103..87869469 [GRCh37] Chr4:81184127..88088493 [NCBI36] Chr4:4q21.21-21.3 |
pathogenic |
GRCh38/hg38 4q13.2-22.3(chr4:68686088-95294456)x3 | copy number gain | See cases [RCV000143458] | Chr4:68686088..95294456 [GRCh38] Chr4:69551806..96215607 [GRCh37] Chr4:69234401..96434630 [NCBI36] Chr4:4q13.2-22.3 |
pathogenic |
GRCh37/hg19 4p16.3-q35.2(chr4:12440-190904441)x3 | copy number gain | See cases [RCV000446653] | Chr4:12440..190904441 [GRCh37] Chr4:4p16.3-q35.2 |
pathogenic |
GRCh37/hg19 4q21.21-22.1(chr4:82283358-90341831)x1 | copy number loss | See cases [RCV000447691] | Chr4:82283358..90341831 [GRCh37] Chr4:4q21.21-22.1 |
pathogenic |
GRCh37/hg19 4p16.3-q35.2(chr4:68346-190957473) | copy number gain | See cases [RCV000510453] | Chr4:68346..190957473 [GRCh37] Chr4:4p16.3-q35.2 |
pathogenic |
GRCh37/hg19 4q21.22-21.23(chr4:83954528-85807754)x1 | copy number loss | See cases [RCV000510348] | Chr4:83954528..85807754 [GRCh37] Chr4:4q21.22-21.23 |
uncertain significance |
GRCh37/hg19 4q21.23(chr4:84780467-85971501)x1 | copy number loss | See cases [RCV000511522] | Chr4:84780467..85971501 [GRCh37] Chr4:4q21.23 |
uncertain significance |
GRCh37/hg19 4p16.3-q35.2(chr4:68346-190957473)x3 | copy number gain | See cases [RCV000512241] | Chr4:68346..190957473 [GRCh37] Chr4:4p16.3-q35.2 |
pathogenic |
GRCh37/hg19 4q21.21-22.3(chr4:81314915-96636651)x1 | copy number loss | not provided [RCV000682426] | Chr4:81314915..96636651 [GRCh37] Chr4:4q21.21-22.3 |
pathogenic |
GRCh37/hg19 4p16.3-q35.2(chr4:49450-190963766)x3 | copy number gain | not provided [RCV000743156] | Chr4:49450..190963766 [GRCh37] Chr4:4p16.3-q35.2 |
pathogenic |
GRCh37/hg19 4p16.3-q35.2(chr4:11525-191028879)x3 | copy number gain | not provided [RCV000743147] | Chr4:11525..191028879 [GRCh37] Chr4:4p16.3-q35.2 |
pathogenic |
GRCh37/hg19 4p16.3-q35.2(chr4:49450-190915650)x3 | copy number gain | not provided [RCV000743155] | Chr4:49450..190915650 [GRCh37] Chr4:4p16.3-q35.2 |
pathogenic |
GRCh37/hg19 4q21.21-22.1(chr4:80482400-92572499)x1 | copy number loss | See cases [RCV000790579] | Chr4:80482400..92572499 [GRCh37] Chr4:4q21.21-22.1 |
pathogenic |
GRCh37/hg19 4q21.21-22.1(chr4:82043901-88334228) | copy number loss | not provided [RCV000767792] | Chr4:82043901..88334228 [GRCh37] Chr4:4q21.21-22.1 |
pathogenic |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:1800 | AgrOrtholog |
COSMIC | CDS1 | COSMIC |
Ensembl Genes | ENSG00000163624 | ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Protein | ENSP00000295887 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000421316 | UniProtKB/TrEMBL | |
Ensembl Transcript | ENST00000295887 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000511298 | UniProtKB/TrEMBL | |
GTEx | ENSG00000163624 | GTEx |
HGNC ID | HGNC:1800 | ENTREZGENE |
Human Proteome Map | CDS1 | Human Proteome Map |
InterPro | PC_trans | UniProtKB/Swiss-Prot |
PC_Trfase_euk | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:1040 | UniProtKB/Swiss-Prot |
NCBI Gene | 1040 | ENTREZGENE |
OMIM | 603548 | OMIM |
PANTHER | PTHR13773 | UniProtKB/Swiss-Prot |
PharmGKB | PA26346 | PharmGKB |
PIRSF | PC_trans_euk | UniProtKB/Swiss-Prot |
PROSITE | CDS | UniProtKB/Swiss-Prot |
UniGene | Hs.654899 | ENTREZGENE |
Hs.708641 | ENTREZGENE | |
UniProt | A0A024RDG8 | ENTREZGENE, UniProtKB/TrEMBL |
CDS1_HUMAN | UniProtKB/Swiss-Prot | |
D6RGC8_HUMAN | UniProtKB/TrEMBL | |
Q92903 | ENTREZGENE | |
UniProt Secondary | B2RAL5 | UniProtKB/Swiss-Prot |
O00163 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2015-12-08 | CDS1 | CDP-diacylglycerol synthase 1 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 | Symbol and/or name change | 5135510 | APPROVED | |
2011-09-01 | CDS1 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 | CDS1 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 | Symbol and/or name change | 5135510 | APPROVED |
![]() |
More on CDS1 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 734044 |
Created: | 2004-01-12 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.